Wang-Jian Zhang Selected Research

Chemoradiotherapy

5/2024	The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.
2/2024	Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities.
10/2023	Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study.
1/2023	The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy.
10/2022	Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?
1/2022	Development of a web-based prognostic model to quantify the survival benefit of cumulative cisplatin dose during concurrent chemoradiotherapy in childhood nasopharyngeal carcinoma.
11/2021	Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study.
1/2021	Optimal cumulative cisplatin dose during concurrent chemoradiotherapy among children and adolescents with locoregionally advanced nasopharyngeal carcinoma: A real-world data study.
1/2019	Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?
7/2018	The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wang-Jian Zhang Research Topics

Disease

29	Nasopharyngeal Carcinoma 05/2024 - 09/2015
10	Neoplasms (Cancer) 05/2024 - 07/2017
4	Neoplasm Metastasis (Metastasis) 01/2018 - 07/2017
2	Mucositis 01/2019 - 03/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022
1	Inflammation (Inflammations) 01/2022
1	Allergic Rhinitis 09/2021
1	Papillary Thyroid Cancer 01/2021
1	Dermatitis 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Leukopenia 03/2017
1	Xerostomia 03/2017
1	Hearing Loss (Hearing Impairment) 03/2017
1	Neutropenia 03/2017
1	Mastoiditis 01/2016

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2021
1	Gemcitabine FDA Link 05/2024
1	OzoneIBA 09/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019
1	BilirubinIBA 09/2018
1	nimotuzumabIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	nitazoxanide (NTZ)FDA Link 01/2018
1	AntibodiesIBA 08/2017
1	Immunoglobulin A (IgA)IBA 08/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2017

Therapy/Procedure

14	Chemoradiotherapy 05/2024 - 01/2016
12	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2021 - 09/2015
9	Neoadjuvant Therapy 02/2024 - 01/2016
9	Radiotherapy 01/2023 - 01/2016
2	Induction Chemotherapy 05/2024 - 01/2019
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Thyroidectomy 01/2021
1	Drug Therapy (Chemotherapy) 01/2016
1	Therapeutics 09/2015